# A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients

> **NCT00929981** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 80 (actual)

## Conditions studied

- Dermatitis, Contact

## Interventions

- **DRUG:** Tablet Methylprednisolone (4 or 16 mg)

## Key facts

- **NCT ID:** NCT00929981
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929981, "A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00929981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*